JASON ZHUANG
Cliffside Park,USA
Summary
Sell-side Equity Research Associate with ~4 years of experience covering US large cap biopharma.
Overview
4
4
years of professional experience
1
1
Certification
Work History
Equity Research Associate
Leerink Partners LLC
12.2023 - Current
- Equity Research Associate covering US Diversified Biopharma, incl. ABBV, BMY, PFE, JNJ, LLY, REGN, AMGN, SAN FP, VRTX, HALO, XOMA, CNTA, ANAB, ROIV, GPCR, PCVX.
- Senior Analyst: David Risinger
- Conducted extensive research on Washington policies, including drug pricing, tariffs, MFN, and FDA.
- Wrote research notes and therapeutics deep dives; Built and maintained financial models.
- Interacted with investors on a daily basis.
Equity Research Associate
BNP Paribas Securities Corp
08.2022 - 12.2023
- Sell-side equity research associate focusing on US healthcare, Specialty Pharma / Large- Cap Pharma / Biotechnology.
- Senior analyst: Navann Ty.
- Covering: ABBV, MRK, OGN, HOLX, NTRA, SKIN, RVNC, EOLS, COO, KVUE, ELAN, ZTS, PAHC, IDXX
- Functioned as the only associate on the team
- Prepared 3-statement financial models with DCF/multiple valuation for initiation
- Wrote earnings reviews and flash notes, updated model and projections
- Communicated with company management and KOLs, wrote takeaway notes
- Organized fireside chats with well-reputed scientists on female aging and GeroScience
Equity Research Analyst
Haitong Securities USA
11.2021 - 07.2022
- Sell-side equity research analyst with a focus on China biotech, and US biopharma.
- Senior Analyst: Linda Shu
- Conducted research on the correlation between US interest rate and US biotech stock prices (NBI, XBI)
- Facilitated the preparation of AI drug development industry report (RXRX, SDGR, EXAI, Insilico)
- Communicated with China and US investors, company management and KOLs
- Tracked and managed global COVID-19 data, sent early alerts about Omicron in South Africa to Chinese investors
Education
Master of Public Health - Epidemiology, Biostatistics, Virology
Cornell University
Ithaca, New York05.2021
Bachelor of Science - Pharmaceutical Science, Biochemistry, Pharmacology
Fudan University
07.2019
Certification
- Series 63, 86&87, FINRA
- SIE, FINRA
- Financial Modeling, CFA Institute
Timeline
Equity Research Associate
Leerink Partners LLC
12.2023 - Current
Equity Research Associate
BNP Paribas Securities Corp
08.2022 - 12.2023
Equity Research Analyst
Haitong Securities USA
11.2021 - 07.2022
Bachelor of Science - Pharmaceutical Science, Biochemistry, Pharmacology
Fudan University
Master of Public Health - Epidemiology, Biostatistics, Virology
Cornell University